FIELD: technological processes.
SUBSTANCE: present invention relates to a method for purifying epidaunorubicin, which can be used in biotechnology. Such proposed method includes the following steps: a) providing a mixture comprising epidaunorubicin, epifeudomycin, and at least one halogenated solvent; b) adjusting the pH of the mixture in the range of 5.0 to 7.5; c) heating the mixture in step b) to the temperature greater than 25 °C; and d) purification of epidaunorubicin, and is characterized in that the content of alcohols with 1 to 5 carbon atoms in the mixture in steps a) and b) is no more than 5 vol., based on the total volume of the mixture.
EFFECT: new effective method for removing epifeudomycin from epidaunorubicin, the former is formed as a by-product in the biotechnological production of epidaunorubicin, is proposed.
12 cl, 1 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
CRYSTALLISATION OF 4′-EPIDAUNORUBICINE X HCI | 2010 |
|
RU2564415C2 |
METHOD FOR PURIFYING FERMENTATION BROTH | 2001 |
|
RU2265665C2 |
ISOLATION OF CAROTINOID CRYSTALS | 2001 |
|
RU2256651C2 |
METHOD OF PREPARING AND/OR PURIFYING CLAVULANIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS THEREOF CLAVULANIC ACID SALT WITH AMINO ACID | 1993 |
|
RU2105768C1 |
ADJUVANT COMPOSITION CONTAINING 3-O-DEACYLATED 4′-MONOPHOSPHORYL LIPID A | 2006 |
|
RU2427378C2 |
METHOD OF EXTRACTING MOLECULES FORMED DURING ANAEROBIC FERMENTATION FROM FERMENTATION BIOMASS | 2015 |
|
RU2692618C2 |
METHOD OF PREPARING CLAVULANIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS | 1995 |
|
RU2088586C1 |
METHODS OF PROCESSING LIGNOCELLULOSIC MATERIALS | 2013 |
|
RU2634700C2 |
PROCESS FOR PREPARATION OF IOPAMIDOL | 2014 |
|
RU2657238C2 |
POLYSACCHARIDE FROM ECHINACEA ANGUSTIFOLIA ROOTS, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2308460C2 |
Authors
Dates
2018-07-24—Published
2015-04-30—Filed